Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
INDUSTRY
×
danvatirsen
×
Clear all
Filters
3
NCT05814666
2026-01-30
PEMDA-HN
Flamingo Therapeutics NV
Phase 2
Terminated
69 enrolled
21 charts
NCT03334617
2025-10-27
HUDSON
AstraZeneca
Phase 2
Active not recruiting
528 enrolled
16 charts